Brief: Vigil Neuroscience Q1 EPS USD -0.49 Vs. IBES Estimate USD -0.53
May 07 (Reuters) - Vigil Neuroscience Q1 net income USD -22.413 million vs. IBES estimate USD -24 million. Q1 operating expenses USD 23.469 million Q1 operating income USD -23.469 million vs. IBES estimate USD -24.8 million
Recent news on Vigil Neuroscience
See all newsVigil Neuroscience Inc reports results for the quarter ended June 30 - Earnings Summary
Vigil Neuroscience Inc expected to post a loss of 42 cents a share - Earnings Preview
Brief: Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP
U.S. RESEARCH ROUNDUP-Ralph Lauren, Vigil Neuroscience, Workday
Deals of the day-Mergers and acquisitions